Metastatic Hormone Refractory Prostate Cancer Recruiting Phase 1 Trials for Prednisone (DB00635)

Also known as: Metastatic hormone refractory Prostate cancer / Metastatic Prostate cancer / Prostate cancer metastatic / Metastatic Prostate Carcinoma / Carcinoma of the prostate metastatic / Prostatic cancer metastatic

DBCOND0036371 (Metastatic Hormone Refractory Prostate Cancer)Recruiting1 IdentifierTitlePurposeDrugs
NCT02913196Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPCTreatment
NCT04179864Study of Tazemetostat Together With Enzalutamide or With Abiraterone/Prednisone in Subjects With Castration Resistant Prostate Cancer That Has Spread Who Have Not Yet Received ChemotherapyTreatment